Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

Autor:	Berenguer, Juan, González, Juan, Ribera, Esteban, Domingo, Pere, Santos, Jesús, Miralles, Pilar, Ribas, Ma. Angels, Asensi, Víctor, Gimeno, Juan Luis, Pérez-Molina, José Antonio, Terrón, José Alberto, Santamaría, Juan Miguel, Pedrol, Enric
Zdroj:	Clinical Infectious Diseases, 2008 Oct . 47(8), 1083-1092.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/40308224 Zobrazit plný text záznamu